Mergers & Acquisitions ·
Black Hawk Acquisition Corp entered into financing agreements with Meteora Select Trading Opportunities Master LP to…
BKHABlack Hawk Acquisition Corp
Black Hawk Acquisition Corp entered into financing agreements with Meteora Select Trading Opportunities Master LP to support its business combination with Vesicor Therapeutics. The transaction includes a Forward Purchase Agreement for up to 1,350,000 shares at an initial reset price of $10.00 per share and a Non-Redemption Agreement where Meteora agreed not to redeem up to 2,124,077 shares. Additionally, the parties executed a Standby Equity Purchase Agreement (SEPA) allowing PubCo to sell up to $200 million in common stock over 36 months at 97% of market price, along with Registration Rights Agreements for resale. Black Hawk Acquisition Corp operates as a blank check company focused on merging with Vesicor Therapeutics, Inc., a biotechnology firm.